FDA Approved: STIVARGA — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved STIVARGA (regorafenib) based on Bayer's original application for patients with metastatic colorectal cancer who have progressed after standard …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

ORIG AP for STIVARGA (REGORAFENIB)